Pfizer stock

pfizer stock

What will be Pfizers stock price in the next year?

13 brokerages have issued 12 month price targets for Pfizers stock. Their forecasts range from $24.00 to $43.00. On average, they expect Pfizers share price to reach $39.64 in the next year. This suggests a possible upside of 0.7% from the stocks current price.

What are analystsprice targets for Pfizers stock?

13 Wall Street analysts have issued 12 month price objectives for Pfizers stock. Their forecasts range from $41.00 to $60.00. On average, they expect Pfizers stock price to reach $46.31 in the next twelve months. This suggests that the stock has a possible downside of 6.6%.

What kind of company is Pfizer?

Something went wrong while loading Watchlist. Pfizer Inc. is a research-based global biopharmaceutical company. It engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide.

Who are Pfizers top shareholders?

Pfizers stock is owned by a variety of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (7.33%), Capital World Investors (4.30%), Wellington Management Group LLP (3.94%), Geode Capital Management LLC (1.78%), State Farm Mutual Automobile Insurance Co. (0.96%) and Morgan Stanley (0.83%).

Will Pfizer’s stock hit $61 this year?

The low-end Pfizer stock price forecast suggests there will be a 13.5% fall to $38, while the median prediction is that PFE’s stock will rise by 0.3% to $44. At the most optimistic end of the scale, there’s a prediction that the Pfizer share price will hit $61 this year – a 39% surge.

What is Pfizers price targets for the next year?

On average, they anticipate Pfizers stock price to reach $44.93 in the next year. This suggests a possible upside of 22.7% from the stocks current price. View Analyst Price Targets for Pfizer.

What is the forecast for Pfizer stock for March 2022?

Averaged Pfizer stock price for month 49.74. Price at the end 47.30, change for February -10.87%. Pfizer stock predictions for March 2022. The forecast for beginning of March 47.30. Maximum value 48.87, while minimum 43.33. Averaged Pfizer stock price for month 46.40. Price at the end 46.10, change for March -2.54%. Pfizer Stock Forecast By Month.

Is Pfizer Inc (PFE) stock undervalued?

Over the next 52 weeks, Pfizer Inc has on average historically risen by 11.4 % based on the past 49 years of stock performance. Is Pfizer Inc Stock Undervalued? The current Pfizer Inc [ PFE] share price is $52.08. The Score for PFE is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.

Over the previous 90 days, Pfizers stock had 2 upgrades by analysts. Does Pfizers stock price have much upside? According to analysts, Pfizers stock has a predicted upside of 11.17% based on their 12-month price targets. What analysts cover Pfizer?

Should you buy Pfizer (PFE) stock?

Is Pfizer a publicly traded company?

Pfizer is a publicly-traded global pharmaceutical company headquartered in New York City. Its revenues reached $51.8 billion in 2019. Pfizer makes Eliquis, Enbrel, EpiPen, Depo-Provera, Dimetapp, Neosporin, Xeljanz and Zithromax/Zmax. It specializes in vaccines and cancer, heart and diabetes treatments.

Why is Pfizer called Pfizer?

The name of the company commemorates its co-founder, Charles Pfizer (1824-1906). Pfizer develops and produces medicines and vaccines for immunology, oncology, cardiology, endocrinology, and neurology. The company has several blockbuster drugs or products that each generate more than US$1 billion in annual revenues.

What is the main product of Pfizer?

Pfizer is a research-based multinational biopharmaceutical group. The Company is engaged in the developing, production and sale of prescription and over-the-counter medications and healthcare products. Pfizer’s product portfolio spans medicines, vaccines and medical devices, as well as consumer healthcare products.

What is Pfizer’s net worth?

What Is Pfizer? Pfizer is a publicly-traded global pharmaceutical company headquartered in New York City. Its revenues reached $51.8 billion in 2019. Pfizer makes Eliquis, Enbrel, EpiPen, Depo-Provera, Dimetapp, Neosporin, Xeljanz and Zithromax/Zmax.

What type of owners hold Pfizer Inc stock? Name Hold Shares Value Vanguard Group Inc 8.06% 450,914,119 $17.91B Blackrock Inc 7.25% 405,733,970 $16.12B State Street Corp 4.91% 274,886,855 $10.92B Wellington Management Group Llp 4.46% 249,780,583 $9.92B 6 more rows ...

What are the best Pfizer mutual funds?

Postagens relacionadas: